Non-Current Liabilities
Long-Term Debt
Idexx Laboratories Long-Term Debt decreased by 20.0% to $299.85M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 33.3%, from $449.80M to $299.85M. Over 5 years (FY 2020 to FY 2025), Long-Term Debt shows a downward trend with a -15.3% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Liabilities
CategoryLeverage
SignalContext dependent
VolatilityStable
First reportedQ3 2016
Last reportedQ4 2025
How to read this metric
An increase indicates higher financial leverage, which can amplify returns on equity but also increases interest expense and financial risk.
Detailed definition
Loans and financial obligations with a maturity period exceeding one year, typically consisting of corporate bonds and n...
Peer comparison
Capital-intensive firms or those with aggressive share buyback programs often carry higher long-term debt than asset-light competitors.
Metric ID:
long_term_debtHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $780.08M | $778.03M | $775.21M | $773.38M | $768.00M | $760.81M | $694.39M | $696.36M | $696.84M | $618.81M | $622.88M | $620.78M | $524.74M | $524.76M | $449.79M | $449.80M | $449.81M | $374.83M | $374.84M | $299.85M |
| QoQ Change | — | -0.3% | -0.4% | -0.2% | -0.7% | -0.9% | -8.7% | +0.3% | +0.1% | -11.2% | +0.7% | -0.3% | -15.5% | +0.0% | -14.3% | +0.0% | +0.0% | -16.7% | +0.0% | -20.0% |
| YoY Change | — | — | — | — | -1.5% | -2.2% | -10.4% | -10.0% | -9.3% | -18.7% | -10.3% | -10.9% | -24.7% | -15.2% | -27.8% | -27.5% | -14.3% | -28.6% | -16.7% | -33.3% |
Range$299.85M – $780.08M
CAGR-18.2%
Avg YoY Growth-16.3%
Median YoY Growth-14.7%
Long-Term Debt at Other Companies
Frequently Asked Questions
- What is Idexx Laboratories's long-term debt?
- Idexx Laboratories (IDXX) reported long-term debt of $299.85M in Q1 2026.
- How has Idexx Laboratories's long-term debt changed year-over-year?
- Idexx Laboratories's long-term debt decreased by 33.3% year-over-year, from $449.80M to $299.85M.
- What is the long-term trend for Idexx Laboratories's long-term debt?
- Over 5 years (2020 to 2025), Idexx Laboratories's long-term debt has grown at a -15.3% compound annual growth rate (CAGR), from $858.49M to $374.84M.
- What does long-term debt mean?
- Money the company has borrowed that doesn't need to be paid back for at least a year.